Related Experiment Video

Updated: Aug 18, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

EGFR tyrosine kinase domain mutations in human gliomas

Y Marie1, A F Carpentier, A M P Omuro

  • 1Department of Neurology Mazarin and Institut National de la Santé et de la Recherche Médicale UMR-495, Paris, France.

Neurology
|April 27, 2005
PubMed

Insights

Gefitinib, an EGFR inhibitor, showed no mutations in 95 gliomas. This suggests different EGFR biology in brain tumors, potentially explaining glioblastoma resistance to this lung cancer drug.

Area of Science:

  • Oncology
  • Molecular Biology
  • Neuro-oncology

Background:

  • Gefitinib targets epidermal growth factor receptor (EGFR) tyrosine kinase.
  • EGFR mutations in exons 19 and 21 are key for gefitinib efficacy in lung cancer.

Purpose of the Study:

  • To investigate EGFR mutations in various glioma types.
  • To explore the potential role of EGFR in glioma biology and gefitinib resistance.

Main Methods:

  • Analysis of EGFR mutations in 95 glioma samples.
  • Inclusion of glioblastomas, anaplastic oligodendrogliomas, and low-grade gliomas.

Main Results:

  • No EGFR mutations were detected in any of the 95 glioma samples.
  • This finding contrasts with the known prevalence of EGFR mutations in lung cancer.

Conclusions:

  • The biological behavior of EGFR in gliomas differs significantly from that in lung cancer.
  • The absence of EGFR mutations may contribute to the observed resistance of glioblastomas to gefitinib therapy.

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...